Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Cardiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology of obstructive sleep apnea: a population health perspective.Am J Respir Crit Care Med. 2002; 165: 1217-1239
- Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.J Thorac Dis. 2015; 7: 1311-1322
- Sleep-disordered breathing in heart failure- a therapeutic dilemma.Circ J. 2017; 81: 903-912
- Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients.Eur J Heart Fail. 2007; 9: 251-257
- Pathophysiology of sleep apnea.Physiol Rev. 2010; 90: 47-112
- Adult obstructive sleep apnoea.Lancet. 2014; 383: 736-747
- Central sleep apnea.Compr Physiol. 2013; 3: 141-163
- Heart failure and sleep apnea.Can J Cardiol. 2015; 31: 898-908
- Distinct patterns of hyperpnea during Cheyne-Stokes respiration: implication for cardiac function in patients with heart failure.J Clin Sleep Med. 2017; 13: 1235-1241
- A high prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction.Eur J Heart Fail. 2007; 9: 243-250
- Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea.Circulation. 2003; 107: 1998-2003
- Cheyne-Stokes respiration: friend or foe?.Thorax. 2012; 67: 357-360
- Congestive heart failure and central sleep apnea.Crit Care Clin. 2015; 31: 473-495
- Increased prevalence of sleep-disordered breathing in adults.Am J Epidemiol. 2013; 177: 1006-1014
- Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure.J Card Fail. 2012; 18: 534-540
- Influence of obstructive sleep apnea on mortality in patients with heart failure.J Am Coll Cardiol. 2007; 49: 1625-1631
- Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure.Eur Heart J. 2011; 32: 61-74
- Relationship between sleep apnoea and mortality in patients with ischaemic heart failure.Heart. 2009; 95: 819-824
- Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure.Am J Respir Crit Care Med. 2013; 187: 433-438
- Augmented sympathetic neural response to simulated obstructive apnoea in human heart failure.Clin Sci (Lond). 2003; 104: 231-238
- Interactive effects of hypoxia, hypercapnia and lung volume on sympathetic nerve activity in humans.Exp Physiol. 2015; 100: 1018-1029
- The sympathetic/parasympathetic imbalance in heart failure with reduced ejection fraction.Eur Heart J. 2015; 36: 1974-1982b
- Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure.Lancet. 1991; 338: 1480-1484
- Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure.Chest. 2008; 133: 690-696
- A mechanism of central sleep apnea in patients with heart failure.N Engl J Med. 1999; 341: 949-954
- Cycle length of periodic breathing in patients with and without heart failure.Am J Respir Crit Care Med. 1996; 154: 376-381
- Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.Am J Respir Crit Care Med. 1999; 160: 1101-1106
- Chronic intermittent hypoxia exposure improves left ventricular contractility in transgenic mice with heart failure.J Appl Physiol (1985). 2012; 113: 791-798
- Can cardiorespiratory polygraphy replace portable polysomnography in the assessment of sleep-disordered breathing in heart failure patients?.Sleep Breath. 2014; 18: 475-482
- Management of sleep apnea in heart failure.Heart Fail Clin. 2018; 14: 635-642
- 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.J Card Fail. 2017; 23: 628-651
- Rationale, design, and endpoints of the 'DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)' study: Prospective multicenter observational study of device-detected tachyarrhythmia and sleep-disordered breathing.Int J Cardiol. 2019; 280: 69-73
- Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing.Eur J Heart Fail. 2007; 9: 820-826
- Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.Lancet. 1994; 343: 572-575
- Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea.N Engl J Med. 2003; 348: 1233-1241
- Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure.Am J Respir Crit Care Med. 2004; 169: 361-366
- Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study.Sleep Med. 2008; 9: 660-666
- Sleep apnea testing and outcomes in a large cohort of Medicare beneficiaries with newly diagnosed heart failure.Am J Respir Crit Care Med. 2011; 183: 539-546
- CPAP for prevention of cardiovascular events in obstructive sleep apnea.N Engl J Med. 2016; 375: 919-931
- The Sleep Apnea Cardiovascular Endpoints (SAVE) study: implications for health services and sleep research in China and elsewhere.J Thorac Dis. 2017; 9: 2217-2220
- Continuous positive airway pressure for central sleep apnea and heart failure.N Engl J Med. 2005; 353: 2025-2033
- Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP).Circulation. 2007; 115: 3173-3180
- Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.J Am Coll Cardiol. 1997; 30: 739-745
- Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea.Am J Respir Crit Care Med. 1995; 152: 473-479
- Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure.Am J Respir Crit Care Med. 1995; 151: 92-97
- Adaptive servo-ventilation for central sleep apnea in systolic heart failure.N Engl J Med. 2015; 373: 1095-1105
- Cardiac output response to continuous positive airway pressure in congestive heart failure.Am Rev Respir Dis. 1992; 145: 377-382
- Effect of adaptive servo-ventilation on periodic limb movements in sleep in patients with heart failure.Am J Cardiol. 2019; 123: 632-637
- Design of the effect of adaptive servo-ventilation on survival and cardiovascular hospital admissions in patients with heart failure and sleep apnoea: the ADVENT-HF trial.Eur J Heart Fail. 2017; 19: 579-587
- Predictors of one year compliance with adaptive servo-ventilation in patients with heart failure and sleep- disordered breathing: preliminary data from the ADVENT-HF trial.Eur Respir J. 2019; 53 ([pii:1801626])
- Transvenous stimulation of the phrenic nerve for the treatment of central sleep apnoea: 12 months' experience with the remede((R)) System.Eur J Heart Fail. 2016; 18: 1386-1393
- Phrenic nerve stimulation to treat patients with central sleep apnoea and heart failure.Eur J Heart Fail. 2018; 20: 1746-1754
- Effects of nocturnal oxygen therapy in patients with chronic heart failure and central sleep apnea: CHF-HOT study.Heart Vessels. 2016; 31: 165-172
- Nocturnal oxygen therapy in patients with chronic heart failure and sleep apnea: a systematic review.Sleep Med. 2016; 17: 149-157
- Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure.Ann Am Thorac Soc. 2014; 11: 80-86
Article Info
Footnotes
This article originally appeared in Heart Failure Clinics, Volume 16, Issue 1, January 2020.
Disclosure: Dr R.J. Mentz has received research support from ResMed . Dr A.C. Coniglio has no relevant disclosures.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
